Intranasal murine model of Bordetella pertussis infection. I. Prediction of protection in human infants by acellular vaccines

This publication has 15 references indexed in Scilit:

• A search for serologic correlates of immunity to Bordetella pertussis cough illnesses
  Vaccine, 1998
• Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis
  Vaccine, 1998
• A Comparative Efficacy Trial in Germany in Infants Who Received Either the Lederle/Takeda Acellular Pertussis Component DTP (DTaP) Vaccine, the Lederle Whole-Cell Component DTP Vaccine, or DT Vaccine
  Pediatrics, 1998
• Efficacy of a two-component acellular pertussis vaccine in infants
  The Pediatric Infectious Disease Journal, 1997
• A randomized double-blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in Senegal
  Vaccine, 1997
• A Controlled Trial of a Two-Component Acellular, a Five-Component Acellular, and a Whole-Cell Pertussis Vaccine
  New England Journal of Medicine, 1996
• A Controlled Trial of Two Acellular Vaccines and One Whole-Cell Vaccine against Pertussis
  New England Journal of Medicine, 1996
• Efficacy of acellular pertussis vaccine in early childhood after household exposure
  Published by American Medical Association (AMA) ,1996
• A Simple Chemically Defined Medium for the Production of Phase I Bordetella pertussis
  Journal of General Microbiology, 1970
• Mouse Protection Tests in the Study of Pertussis Vaccine
  American Journal of Public Health and the Nations Health, 1947